Ledger.Open graph →

SEC Form D · filed July 3, 2019

IMPEL NEUROPHARMA INC

Offering

$1.6M

Sold

—

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

William Toms · SAN FRANCISCO, CAExec · Director Alexis Bjorlin · Sunnyvale, CAExec Thomas Ritter · Chicago, ILDirector Michael Ettling · Miami, FLDirector Anthony B. Davis · Chicago, ILDirector David Lazovsky · Sunnyvale, CADirector Terrence Schmid · SAN FRANCISCO, CAExec · Director Brian B. Miller · Chicago, ILDirector Andrew Parker · Chicago, ILDirector Jocelyn White · London, United KingdomDirector Raphael Schorr · Boston, MADirector Michael Coe · Perry, KSDirector Jay Po · LINCOLN, MADirector Karim Faris · Boston, MADirector Megan A. Bailey · Baltimore, MDDirector Stephan Cubba · Detroit, MIExec · Director Ping Wang · MOUNTAIN VIEW, CADirector Yanjuan Chen · MOUNTAIN VIEW, CAExec · Director Brian Fitzpatrick · Miami Lakes, FLExec Johnson Agogbua · Reston, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗